Athira Pharma, Inc.
ATHA
$0.2487
$0.00974.06%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 26.09M | 26.86M | 27.13M | 31.28M | 33.30M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 96.78M | 111.85M | 121.40M | 125.01M | 127.09M |
| Operating Income | -96.78M | -111.85M | -121.40M | -125.01M | -127.09M |
| Income Before Tax | -96.94M | -109.22M | -113.45M | -116.19M | -117.67M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -96.94 | -109.22 | -113.45 | -116.19 | -117.67 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -96.94M | -109.22M | -113.45M | -116.19M | -117.67M |
| EBIT | -96.78M | -111.85M | -121.40M | -125.01M | -127.09M |
| EBITDA | -95.81M | -110.88M | -120.43M | -124.04M | -126.13M |
| EPS Basic | -2.52 | -2.85 | -2.97 | -3.05 | -3.10 |
| Normalized Basic EPS | -1.51 | -1.75 | -1.89 | -1.94 | -1.97 |
| EPS Diluted | -2.52 | -2.85 | -2.97 | -3.05 | -3.10 |
| Normalized Diluted EPS | -1.51 | -1.75 | -1.89 | -1.94 | -1.97 |
| Average Basic Shares Outstanding | 153.92M | 153.32M | 152.86M | 152.48M | 152.08M |
| Average Diluted Shares Outstanding | 153.92M | 153.32M | 152.86M | 152.48M | 152.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |